Concepedia

Volodymyr Gavrysyuk

VG

Statistics

Publications

4

Citations

641

H-Index

4

Active since

2017

Affiliations

Actelion (Switzerland)(Current)

Universities of Giessen and Marburg Lung Center

Papworth Hospital

University of California System

Imperial College London

Volodymyr Gavrysyuk is an author at Actelion (Switzerland) specializing in pharmacotherapy, pulmonology, and clinical pharmacology.

Publications per year

2017–2024

4

Publications

4

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

, , +6

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Gérald Simonneau, Andrea Maria D’Armini, Peter F. Fedullo et al. · The Lancet Respiratory Medicine · 2017 · 264 citations

, , +11

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Gérald Simonneau, Andrea Maria D’Armini, Peter F. Fedullo et al. · The Lancet Respiratory Medicine · 2024 · 36 citations

, , +11

Efficacy and Tolerability of Methotrexate and Methylprednisolone in a Comparative Assessment of the Primary and Long-Term Outcomes in Patients with Pulmonary Sarcoidosis

Volodymyr Gavrysyuk, Yaroslav Dziublyk, N. D. Morska et al. · Diagnostics · 2021 · 30 citations · Full text

, , +6

1–4 of 4